Community Fundraising Wrap Up Jan-Mar 2021
15 April 2021
It's been a while since we last recognised the generous support of our amazing community fundraisers. The easing of COVID-19 restrictions has seen the return of some of our annual events and the start of the running event season. We are extremely grateful to our community fundraisers who continue to support us in these challenging times so we can move closer to our goal of zero deaths from melanoma.
Our first annual event to return this year was the Erik Mather 2, 4, 6 Swim hosted by the Balmoral Beach Club. A huge thank you to the entire club and Monika Mather for raising over $50,000 to support MIA’s Erik Mather PhD Scholarship program. Despite the rain, the conditions were perfect for ocean swimming and even MIA’s CEO Matthew Browne, Medical Directors Prof Georgina Long AO and Prof Richard Scolyer, and Prof Anne Cust donned their wetsuits and joined the swim. Congrats to all involved for another successful event!
Last year a much-loved member of the Cockburn Cricket Club Ladies Team was diagnosed with Stage IV melanoma. So, on 20 February the Cockburn Cricket Club held a Ladies' Day with plenty of food, games, and prizes, plus guest speakers - Andrew Kamphaug, from MIA WA and Paige McNeil from the MIA Speakers’ Hub. Thank you to Amanda Rowe and all those who attended to help raise $6,750 for vital life-saving research.
A massive thanks to 'Team Just Keep Swimming' (shown at top from left to right: Tania, Tammie, Anna and Kiara), and solo swimmer Flavia (shown at bottom, second from left, with her support crew) for their incredible efforts during the South32 Rottnest Channel Swim in March. Despite gruelling conditions in the water, the swimmers raised a combined total of $8,510, what an incredible result!
On 28 March, RunWest in Western Sydney was the first event to kick off the running season. We had 26 people representing Team Melanoma who collectively raised $1,140! A big thanks to all who participated and a special shout out to our top three fundraisers: Tara Kairouz, Lisa Duclos,and Sharon Hewitt.
Deb Guion sadly lost her husband, Omri Godijn, to melanoma shortly after his 46th birthday earlier this year. Deb believes MIA's research was instrumental in extending Omri's life by at least 18 months. Deb chose to set up a fundraising page in memory of Omri to support MIA's ongoing research in the hope of changing the outcomes for all future melanoma patients. An enormous thank you to Deb and all your friends and family for raising over $14,000.
We are so thankful for the generous support from all our community fundraisers. Your efforts don't go unnoticed and everything you do helps us move closer to our goal of zero deaths from melanoma, a goal our Co-Medical Directors believe we can reach this decade.
Australian researchers have successfully trialled a combination of new treatments to prevent melanoma from spreading to distant organs.
A new treatment that combines an antibody with a cancer-killing virus improves outcomes for patients with advanced melanoma, an international clinical trial has shown.
It feels like groundhog day - another reality TV show, another batch of blatantly sunburnt contestants.
Wouldn’t it be great if your doctor could know if you would respond to treatment before you even had it?
In our latest research update we showcase research in survival estimates, uncover biomarkers, and reveal practice-changing research in surgery and medical oncology.
Senior Clinical Trial Coordinators, like Sarah Lane, support melanoma patients throughout the clinical trial process.
Melanomas are often hard to differentiate from moles. But new technology is helping to improve accuracy of diagnosis.
We are excited to announce that SunSense will proudly be an official supporter of Melanoma Institute Australia. SunSense is an Australian, family owned business.
Five years ago Julie Randall was diagnosed with melanoma and was given months to live. The melanoma had spread throughout her body. The doctors said it was incurable and she’d be lucky if she survived the next nine months. Julie, a patient at Melanoma Institute Australia under Professor Georgina Long was placed on an experimental drug trial. To watch the entire program, visit 9now.com or click here.
Meet our latest Surgical Oncology Fellow, Eva Nagy, to find out more about life as a surgical oncologist, why she came to MIA and what she hopes to achieve.
Melanoma research at ASCO this year focussed on the more precise use of current treatments to ensure optimal treatment for each patient.
MIA recently demonstrated that reflectance confocal microscopy is a useful tool in the clinic to diagnose suspicious-looking lesions in the mouth.
New research is likely to change the way melanoma is managed in many patients by reducing the need for major surgery and its associated morbidity and cost.
Researchers from MIA will present their latest research findings to the world’s largest oncology conference in early June.
Australian researchers pioneer life-extending treatment for advanced melanoma patients with brain tumours
Australian researchers are the first to demonstrate that patients with advanced melanoma which has spread to the brain can have increased life expectancy and possibly even beat the disease.
Melanoma March 2017 - that's a wrap! Thank you to everyone that helped make it happen.
Thank you so much to all those who contributed in a variety of ways to Melanoma March 2017 in 17 different locations and more around the country! You have contributed to getting the Big Data for Melanoma national Research Project happening!
By looking at the ‘dark matter’ of the genome, new research has found that genetic changes in acral and mucosal melanoma are completely different to mutations found in skin melanoma.
‘Slip, slop, slap’ is synonymous with being Australian and playing it safe in the sun. These sun smart rules reduce our chances of getting melanoma of the skin. However, new research tells a different story for those affected by rarer forms of melanoma.